Skip to main content

Table 5 Open access echocardiography: significant changes in indications, outcomes and specialist advice (SD, %)

From: Evaluation of an open access echocardiography service in the Netherlands: a mixed methods study of indications, outcomes, patient management and trends

Variable First 250 patients Last 250 patients Change p-value
Patient characteristics     
Mean age, in years (SD) 62.6 (18.0) 59.5 (19.1)   0.057
Gender, number of females 147 (58.8) 151 (60.4)   0.715
Indications     
Cardiac murmur only 79 (31.6) 100 (40.0) + 0.050
Any dyspnoea 111 (44.4) 65 (26.0) - 0.000
   Dyspnoea only 50 (20.0) 20 (8.0) - 0.000
   Dyspnoea and peripheral oedema 24 (9.6) 11 (4.4) - 0.023
'Other' indications 41 (16.4) 67 (26.8) + 0.005
   'Other' only 27 (10.8) 55 (22.0) + 0.001
Echocardiographic outcome     
Any LVD 110 (44.0) 85 (34.0) - 0.022
   Diastolic LVD only 95 (38.0) 74 (29.6) - 0.047
Any valve disease 65 (26.0) 43 (17.2) - 0.017
   Mitral insufficiency 18 (7.2) 8 (3.2) - 0.044
   Pulmonary insufficiency 7 (2.8) 0 (0) - 0.008
   Tricuspid insufficiency 21 (8.4) 3 (1.2) - 0.000
LVH 121 (48.4) 99 (39.6) - 0.047
PHT 48 (19.2) 23 (9.2) - 0.001
No disease* 55 (22.0) 82 (32.8) + 0.007
Outcome per indication     
PHT/cardiac murmur 24/131 (18.3) 11/147 (7.5) - 0.007
PHT/dyspnoea 23/111 (20.7) 6/65 (9.2) - 0.047
No disease/dyspnoea 23/111 (20.7) 23/65 (35.4) + 0.033
No disease/'other' 6/41 (14.6) 22/67 (32.8) + 0.036
Cardiologist's advice in patients with positive echocardiographic outcome     
Any advice 78/195 (40.0) 100/168 (59.5) + 0.000
   Repeat echocardiogram in x years 8/195 (4.1) 28/168 (16.7) + 0.000
   Adjust medication 8/195 (4.1) 21/168 (12.5) + 0.003
  1. Abbreviations: LVD left ventricular dysfunction; LVH left ventricular hypertrophy, PHT pulmonary hypertension; + increase; - decrease
  2. *No disease: neither valve disease nor left ventricular dysfunction or left ventricular hypertrophy or pulmonary hypertension or septum defects